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However, for skin activity, there was a significantly elevated risk among those in the very extreme levels of vitamin D. For Renal Disease Activity, there was a significantly higher rate of renal disease activity among those with low levels of vitamin D. In addition, there was a clear trend such that the higher the vitamin D, the lower the risk of renal disease activity. We then conducted a "within person" analysis. In this analysis, each person serves as his own control, and the question is: "When a person has a vitamin D level lower than his/her average, are they more likely to have renal disease activity". Note, this analysis implicitly adjusts for race, sex, and all variables (measured and unmeasured) that are invariant within a person. The results are shown in Table 2 . 
Background:
The benefit of vitamin D on SLE global and renal activity have now been proven by both cohort studies and a clinical trial. The benefits on cardiovascular risk factors, however, are less well understood. Objectives: We present the first longitudinal study on hyperlipidemia. Methods: A within-person aanalysis addressed the question of whether a person tends to have higher cholesterol when her vitamin D is lower than her average vitamin D. To assess this, for each visit, we calculated the difference between the vitamin D level at that visit and the person's average of vitamin D. Differences in the range of vitamin D <50 ng/mL were distinguished from differences in the range above 50 ng/mL. Then we modelled the relationship between these differences in vitamin D and the difference between the person's cholesterol at each visit and the person's average cholesterol. Results: P-value 0-50 ng/mL -3.4 (-3.9, -2.9) <0.0001 -3.1 (-3.6, -2.6) <0.0001 50+ ng/mL -1.1 (-1.7, -0.5) 0.0003 -1.0 (-1.7, -0.4) 0.0016 
